HIV and AIDS Trial, Recruiting NCT05502653 Sponsor: University of Pittsburgh Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05502653
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged between 18 and 80 years old
  • People who are HIV positive
  • People whose HIV virus levels are undetectable (virally suppressed) and have been on HIV treatment for at least 6 months
  • People who are already enrolled in specific studies run by Dr. Morris at the HLRC, or who are receiving care at the HIV/PACT clinics (confirm with trial site)

Who may not be able to join:

  • People for whom breathing/lung function tests would be unsafe, such as those who have had abdominal or cataract surgery within the last 3 months, or who have recently had a heart attack
  • People who have been diagnosed with, or have signs of, another significant lung condition, such as interstitial lung disease or active asthma
  • People who have inflammatory bowel disease
  • People who are pregnant
  • People who have taken antibiotics in the last 2 weeks
  • People who have taken immune-system-altering medications in the last 6 months
  • People who are unable to complete the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alison J Morris, MD, University of Pittsburgh

Phone: 412-624-8330

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Assess intestinal and lung permeability with the lactulose/mannitol differential sugar absorption test; Assess intestinal and lung permeability with the lactulose/mannitol differential sugar absorption test; Assess intestinal and lung permeability with the lactulose/mannitol differential sugar absorption test; BDG levels will be assayed in undiluted plasma samples; BDG levels will be assayed in undiluted plasma samples; BDG levels will be assayed in undiluted plasma samples

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov